… of remarkable population effectiveness against human papillomavirus (HPV), with virtual …
after vaccination of the young Australian female population with the quadrivalent HPV vaccine (…

… theory of HPV vaccine herd effects … vaccine herd effects have now been observed worldwide.
In this paper, we review the theory of vaccine herd effects in the context of HPV vaccination …

… Population-relevant domains are: 1) HPV vaccination in pre-… 2) HPV vaccination in older
individuals; 3) targeted vaccination … and HPV vaccination approaches and 7) alternative vaccine …

… between 2 and 7 oncogenic HPV serotypes. This review … of HPV-related cancers, efficacy
of current HPV vaccines, and speculates about the benefits of widespread HPV vaccination. At …

… option of receiving a two dose HPV vaccine series at either a six month or one year interval
to provide protection from HPV 16, the most … should cause alarms for cancer control officers. …

… Further, to exclude possible prevalent cervical cancers at the date of HPV vaccination, we
used a buffer period of 1 to 5 years at 1-year intervals after the index date of HPV vaccination (…

… The most recent iteration of the preventive HPV vaccine, a nanovalent, L1-VLP vaccine, …
HPV vaccines and discuss the recent progress in the development of therapeutic HPV vaccines. …

… the Americas have introduced HPV vaccines as part of their national immunization programs
and cervical cancer control strategies. Early lessons from HPV vaccine introduction suggest …

… The awareness that human papillomavirus (HPV) is causally … cancer cases has revolutionised
cervical cancer prevention and led to the development of prophylactic HPV vaccines [1]. In …

… HPV vaccination to prevent cervical cancer. Because of all the clinical trials evaluating the
efficacy of HPV vaccines … not know if HPV vaccines are effective in preventing cervical cancer. …